NO20022598L - Krystallisk form av (S)-2-etoksy-3-[4-(2-{4- metansulfonyloksyfenyl}-etoksy)-fenyl]-propansyre - Google Patents

Krystallisk form av (S)-2-etoksy-3-[4-(2-{4- metansulfonyloksyfenyl}-etoksy)-fenyl]-propansyre

Info

Publication number
NO20022598L
NO20022598L NO20022598A NO20022598A NO20022598L NO 20022598 L NO20022598 L NO 20022598L NO 20022598 A NO20022598 A NO 20022598A NO 20022598 A NO20022598 A NO 20022598A NO 20022598 L NO20022598 L NO 20022598L
Authority
NO
Norway
Prior art keywords
ethoxy
methanesulfonyloxyphenyl
phenyl
crystalline form
propanoic acid
Prior art date
Application number
NO20022598A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022598D0 (no
Inventor
Maria Boije
Karol Horvath
Tord Ingardt
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9904416A external-priority patent/SE9904416D0/xx
Priority claimed from SE0001187A external-priority patent/SE0001187D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20022598D0 publication Critical patent/NO20022598D0/no
Publication of NO20022598L publication Critical patent/NO20022598L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20022598A 1999-12-03 2002-05-31 Krystallisk form av (S)-2-etoksy-3-[4-(2-{4- metansulfonyloksyfenyl}-etoksy)-fenyl]-propansyre NO20022598L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9904416A SE9904416D0 (sv) 1999-12-03 1999-12-03 Crystalline form
SE0001187A SE0001187D0 (sv) 2000-04-03 2000-04-03 Crystalline form
PCT/SE2000/002384 WO2001040171A1 (en) 1999-12-03 2000-11-29 Crystalline form of (s)-2 ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid

Publications (2)

Publication Number Publication Date
NO20022598D0 NO20022598D0 (no) 2002-05-31
NO20022598L true NO20022598L (no) 2002-05-31

Family

ID=26655058

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022598A NO20022598L (no) 1999-12-03 2002-05-31 Krystallisk form av (S)-2-etoksy-3-[4-(2-{4- metansulfonyloksyfenyl}-etoksy)-fenyl]-propansyre

Country Status (29)

Country Link
US (1) US6531622B1 (cs)
EP (1) EP1237855B1 (cs)
JP (1) JP2003515582A (cs)
KR (1) KR20030029040A (cs)
CN (1) CN1198799C (cs)
AR (1) AR029412A1 (cs)
AT (1) ATE261431T1 (cs)
AU (1) AU773777B2 (cs)
BR (1) BR0016131A (cs)
CA (1) CA2392038A1 (cs)
CO (1) CO5271735A1 (cs)
CZ (1) CZ20021902A3 (cs)
DE (1) DE60008921T2 (cs)
DK (1) DK1237855T3 (cs)
EE (1) EE200200278A (cs)
ES (1) ES2215769T3 (cs)
HU (1) HUP0203444A3 (cs)
IL (1) IL149577A0 (cs)
IS (1) IS6400A (cs)
MX (1) MXPA02005327A (cs)
MY (1) MY135954A (cs)
NO (1) NO20022598L (cs)
NZ (1) NZ518925A (cs)
PL (1) PL357118A1 (cs)
PT (1) PT1237855E (cs)
RU (1) RU2268880C2 (cs)
SK (1) SK7652002A3 (cs)
TR (1) TR200401333T4 (cs)
WO (1) WO2001040171A1 (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9812770A (pt) 1997-10-27 2000-12-12 Reddy Research Foundation Compostos bicìclicos, processo para seu preparo e composições farmacêuticas contendo os mesmos
WO1999016758A1 (en) 1997-10-27 1999-04-08 Dr. Reddy's Research Foundation Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
AU749505B2 (en) 1997-10-27 2002-06-27 Dr. Reddy's Laboratories Limited Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
UA60386C2 (uk) 1998-10-29 2003-10-15 Reddys Laboratories Ltd Спосіб одержання похідних 3-[4-[2-(феноксазин-10-іл)метокси]феніл]пропіонової кислоти (варіанти) та проміжні сполуки для їх отримання
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
US7084177B2 (en) * 1999-12-03 2006-08-01 Astrazeneca Ab Comminuted form of(S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid
US6897199B2 (en) 2001-02-05 2005-05-24 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP1689383B1 (en) 2003-11-19 2012-10-31 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
EP1586573B1 (en) 2004-04-01 2007-02-07 Sanofi-Aventis Deutschland GmbH Oxadiazolones, processes for their preparation and their use as pharmaceuticals
DE102004035034A1 (de) * 2004-07-20 2006-02-16 Degussa Ag Racematspaltung von p-Hydroxyphenyl-2-alkoxy-propionsäuren
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
MA26634A1 (fr) 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues
SE9801992D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs

Also Published As

Publication number Publication date
EP1237855A1 (en) 2002-09-11
ATE261431T1 (de) 2004-03-15
AR029412A1 (es) 2003-06-25
PL357118A1 (en) 2004-07-12
IL149577A0 (en) 2002-11-10
DE60008921D1 (en) 2004-04-15
CO5271735A1 (es) 2003-04-30
HUP0203444A3 (en) 2003-05-28
MXPA02005327A (es) 2002-12-06
AU773777B2 (en) 2004-06-03
EP1237855B1 (en) 2004-03-10
JP2003515582A (ja) 2003-05-07
PT1237855E (pt) 2004-06-30
DK1237855T3 (da) 2004-06-14
AU2035001A (en) 2001-06-12
RU2268880C2 (ru) 2006-01-27
CZ20021902A3 (cs) 2002-11-13
HK1048980A1 (en) 2003-04-25
DE60008921T2 (de) 2005-01-20
HUP0203444A2 (hu) 2003-02-28
EE200200278A (et) 2003-06-16
SK7652002A3 (en) 2002-11-06
WO2001040171A1 (en) 2001-06-07
CN1409701A (zh) 2003-04-09
US6531622B1 (en) 2003-03-11
CN1198799C (zh) 2005-04-27
NO20022598D0 (no) 2002-05-31
TR200401333T4 (tr) 2004-08-23
RU2002113450A (ru) 2004-01-10
KR20030029040A (ko) 2003-04-11
ES2215769T3 (es) 2004-10-16
NZ518925A (en) 2004-06-25
BR0016131A (pt) 2002-08-20
IS6400A (is) 2002-05-28
MY135954A (en) 2008-07-31
CA2392038A1 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
NO20022598D0 (no) Krystallisk form av (S)-2-etoksy-3-[4-metansulfonyloksyfenyl}- etoksy)-fenyl]-propansyre
LU92025I2 (fr) Méthanesulfonate d'éthylester d'acide 3-¬(2-{¬4-(hexyloxy-carbonylamino-imino-méthyl)-phénylamino-méthyl}-1-méthyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino-propionique
IS6399A (is) Mulið form (S)-2-etoxý-3-[4-(2-{4-metansúlfonýloxýfenýl}etoxý)fenýl]própanónsýra
FI20002767L (fi) Jodoniumsuolat latentteina happodonoreina
DE60007789D1 (de) Folie aus Polymilchsäure
ID28699A (id) Turunan-turunan asam oksiiminoalkanoat
ID26222A (id) Hidroksamida asam(4-arilsulfonilamino)-tetrahidropiran-4-karboksilat
ID26978A (id) Turunan-turunan asam aminometilkarboksilat
ID28833A (id) Turunan asam 3-aril-2-hidroksipropionat
ID22095A (id) Asam aril-akrilat ester
IS5989A (is) Nýtt kristallað form kalíumsalts (S)-ómeprasóls
EE200000717A (et) Uus 3-arüül-2-hüdroksüpropaanhappe derivaat III
ID27390A (id) Pembuatan asam akrilat
EE200000659A (et) 4-(3,5-bis-trifluorometüülbensüülamino)-2-etüül-6-trifluorometüül-3,4-dihüdro-2H-kin oliin-1-karboksüülhappe etüülestrid või nende soolad ja valmistamise meetodid
FI981104L (fi) Ksylitolin kiteytys, kiteinen ksylitolituote ja sen käyttö
ID26379A (id) Katalis asam padat
ID28810A (id) Senyawa-senyawa amida-omega asam n-arilsulfonilamino
FI20002158L (fi) Kaapimen tukilista
EE200100381A (et) Morfolinobensamiidi uued soolad
IL172376A0 (en) Process for the preparation of racemic 2{[2-(4- hydroxyphenyl)ethyl]thio}-3-[4-(2-{4- [(methylsulphonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid
NO20035236D0 (no) Farmasöytisk kombinasjon omfattende enten (S) -2-etoksy-3 (4- (2- (4-metansulfonyloksyfenyl) etoksy) fenyl) propansyre eller 3- (4- (2- (4-tert-butoksykarbonylaminofenyl) etoksy) fenyl) - (S) -2-
DE60112699D1 (de) Selbstklebendes Aufzeichnungspapier
IS8234A (is) Kalíum- eða natríumsalt (-)-2-{[2-(4-hýdroxýfenýl)etýl]þíó}-3-[4-(2-{4-[(metýlsúlfónýl)oxý]fenoxý}fenýl]própansýru og notkun þeirra í læknisfræði
IS7057A (is) Lyfjablanda sem annaðhvort felur í sér (S)-2-etoxý-3-[4-(2-{4-metansúlfónýloxýfenýl} etoxý)fenýl] própansýru eða 3-{4-[2-(4-tert-bútoxýkarbónýlamínófenýl)etoxý]fenýl}-(S)-2-etoxýprópansýru og súlónýlþvagefni
NO994261D0 (no) FremgangsmÕte for fremstilling av trovafloxacinsyresalter